This podcast episode examines Neuralink's initial human trials, analyzing whether they represent a genuine breakthrough in brain-computer interface (BCI) technology or are primarily a public relations (PR) maneuver. It explores Neuralink's vision and technology, detailing the implant and robotic surgical system, and discusses the ambitious long-term goals beyond therapeutic applications. The text also scrutinizes the PRIME Study's early outcomes, highlighting the functional restoration and challenges experienced by the first patients. Furthermore, it places Neuralink within the broader BCI landscape, comparing its approach and performance to other key players while also addressing significant ethical and societal implications, including transparency issues, animal welfare concerns, regulatory challenges, the impact of Elon Musk's communication style, patient safety, data privacy, and the need for neuroethical frameworks.